Literature DB >> 15041084

A single administration of testosterone improves visuospatial ability in young women.

André Aleman1, Erik Bronk, Roy P C Kessels, Hans P F Koppeschaar, Jack van Honk.   

Abstract

Previous research has documented correlations between endogenous testosterone levels and visuospatial cognitive function. Some causal relations have also been established in treatment designs in which testosterone was administered to elderly subjects for a number of weeks. Particularly, one study reported a selective effect of a single administration of testosterone on some aspects of spatial memory in 15 women. The present study tested the hypothesis whether a single administration of 0.5 mg of sublingual testosterone would improve visuospatial ability in healthy young women on a test that has consistently been associated with male superiority. Twenty-six women participated in a double-blind placebo-controlled cross-over trial of single administration of testosterone and placebo. Subjects were tested in the same phase of the menstrual-cycle. Four to five hours after both administrations, subjects completed a standardized measure of visuospatial ability (3-D Mental Rotations Test). Visuospatial ability improved significantly after testosterone administration compared to placebo, after controlling for learning effects due to repeated testing. Testosterone is suggested to be causally related to visuospatial ability in young women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15041084     DOI: 10.1016/S0306-4530(03)00089-1

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  35 in total

1.  Administration of dehydroepiandrosterone (DHEA) enhances visual-spatial performance in postmenopausal women.

Authors:  Bethany Stangl; Elliot Hirshman; Joseph Verbalis
Journal:  Behav Neurosci       Date:  2011-10       Impact factor: 1.912

2.  Age-related changes in matching novel objects across viewpoints.

Authors:  Karin S Pilz; Yaroslav Konar; Quoc C Vuong; Patrick J Bennett; Allison B Sekuler
Journal:  Vision Res       Date:  2011-07-19       Impact factor: 1.886

Review 3.  Testosterone and sport: current perspectives.

Authors:  Ruth I Wood; Steven J Stanton
Journal:  Horm Behav       Date:  2011-10-01       Impact factor: 3.587

Review 4.  Brain sex matters: estrogen in cognition and Alzheimer's disease.

Authors:  Rena Li; Jie Cui; Yong Shen
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

5.  Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women.

Authors:  Richard L Doty; Isabelle Tourbier; Victoria Ng; Jessica Neff; Deborah Armstrong; Michelle Battistini; Mary D Sammel; David Gettes; Dwight L Evans; Natasha Mirza; Paul J Moberg; Tim Connolly; Steven J Sondheimer
Journal:  Neurobiol Aging       Date:  2015-03-10       Impact factor: 4.673

6.  Decreased prevalence of left-handedness among females with male co-twins: evidence suggesting prenatal testosterone transfer in humans?

Authors:  Eero Vuoksimaa; C J Peter Eriksson; Lea Pulkkinen; Richard J Rose; Jaakko Kaprio
Journal:  Psychoneuroendocrinology       Date:  2010-05-31       Impact factor: 4.905

7.  The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia.

Authors:  Andrea Gogos; Perrin Kwek; Maarten van den Buuse
Journal:  Psychopharmacology (Berl)       Date:  2011-07-29       Impact factor: 4.530

8.  Testosterone synthesis in the female songbird brain.

Authors:  Catherine de Bournonville; Aiden McGrath; Luke Remage-Healey
Journal:  Horm Behav       Date:  2020-02-28       Impact factor: 3.587

9.  Mental rotation in human infants: a sex difference.

Authors:  David S Moore; Scott P Johnson
Journal:  Psychol Sci       Date:  2008-11

10.  Region and sex differences in constituent dopamine neurons and immunoreactivity for intracellular estrogen and androgen receptors in mesocortical projections in rats.

Authors:  Mary F Kritzer; Lela M Creutz
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.